University of Southern California
Associate Director, Leukemia/Lymphoma Program-Associate Professor of Clinical Pe
University of Southern California, Glendale, California, us, 91222
Overview
The University of Southern California (USC), founded in 1880, is the largest private employer in the City of Los Angeles. As an employee of USC, you will be part of a world-class research university and a member of the Trojan Family, which includes faculty, students and staff.
The Cancer and Blood Disease Institute (CBDI) at Children’s Hospital Los Angeles (CHLA) and the Division of Hematology-Oncology within the Department of Pediatrics, Keck School of Medicine, USC, are recruiting a Clinical Investigator specializing in hematologic malignancies to serve as Associate Director of the Leukemia/Lymphoma Program. This individual will assist in leadership of clinical and clinical research activities in pediatric hematologic malignancies, partner with the Leukemia/Lymphoma Program Director in program oversight, provide patient care, develop and lead clinical trials, and advance a leading clinical research program.
The ideal candidate will have a minimum of 2 years as an Assistant Professor in Pediatric Hematology-Oncology with a focus in hematologic malignancies and a desire to become a leader in clinical trial development. The position includes membership of the USC Norris Comprehensive Cancer Center and an academic appointment through USC Keck School of Medicine at the level of Assistant Professor, Associate Professor, or Professor, appropriate to training and experience.
Program context The Leukemia/Lymphoma Program at CHLA is one of the largest in the nation and sees approximately 120 new patients each year. The program has robust clinical, translational, and basic science research infrastructure, and CHLA is the headquarters for The Therapeutic Advances in Childhood Leukemia/Lymphoma (TACL) Consortium. Other program highlights include comprehensive genomic characterization, bench-to-bedside investigations of novel agents, and leading cellular therapies. The program maintains a close partnership with the CBDI’s Transplantation and Cellular Therapy Program, which performs 80–100 transplants and 20–40 CAR T-cell therapies annually. The CBDI has a cell processing laboratory and cGMP facility, and is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and the National Marrow Donor Program (NMDP).
The CBDI is the largest and top-ranked pediatric hematology-oncology program in the western United States. The U.S. News & World Report ranked CHLA #8 and the CBDI #14 in the nation in 2022-23. The CBDI has a large clinical trials operation supporting programs in hematology, oncology, and transplantation/cellular therapy. CBDI investigators conduct extensive bench-to-bedside research. Research funding in FY22 totaled $54 million with $9 million in new awards. The CBDI hosts an ACGME-accredited pediatric hematology-oncology fellowship training program and 1-year advanced subspecialty fellowships in Transplantation/Cellular Therapy, AYA Oncology, Neuro-Oncology, and Coagulation.
Responsibilities
Assist in leadership of clinical and clinical research activities in pediatric hematologic malignancies.
Partner with the Leukemia/Lymphoma Program Director in program oversight.
Provide patient care and develop and lead clinical trials.
Advance a leading clinical research program and contribute to program growth.
Qualifications
Minimum of 2 years as an Assistant Professor in Pediatric Hematology-Oncology with a focus in hematologic malignancies.
Desire to become a leader in clinical trial development.
Academic appointment through USC Keck School of Medicine at the level of Assistant Professor, Associate Professor, or Professor, appropriate to training and experience.
Program highlights and resources
Strong administrative, clinical, research, and financial support, including staff, infrastructure, endowments, and institutional resources.
CBDI is affiliated with the USC Norris Comprehensive Cancer Center.
CHLA and USC are equal opportunity, affirmative action employers; diversity is valued and encouraged for applicants from underrepresented groups in medicine.
Compensation The annual base salary range for this position is $116,505–$417,709. When extending an offer of employment, USC considers factors such as scope and responsibilities of the position, work experience, education/training, key skills, internal peer equity, applicable laws, contractual stipulations, grant funding, and external market considerations.
Contact for inquiries Alan S. Wayne, M.D.
Director, Cancer and Blood Disease Institute
Head, Division of Hematology-Oncology
Vice Chair, Department of Pediatrics
Alfred E. Mann Family Foundation Chair in Cancer Research
Children’s Hospital Los Angeles
Associate Director, USC Norris Comprehensive Cancer Center
Professor of Pediatrics and Medicine
Keck School of Medicine, University of Southern California
awayne@chla.usc.edu
REQ20134319 | Posted Date: 05/25/2023
#J-18808-Ljbffr
The Cancer and Blood Disease Institute (CBDI) at Children’s Hospital Los Angeles (CHLA) and the Division of Hematology-Oncology within the Department of Pediatrics, Keck School of Medicine, USC, are recruiting a Clinical Investigator specializing in hematologic malignancies to serve as Associate Director of the Leukemia/Lymphoma Program. This individual will assist in leadership of clinical and clinical research activities in pediatric hematologic malignancies, partner with the Leukemia/Lymphoma Program Director in program oversight, provide patient care, develop and lead clinical trials, and advance a leading clinical research program.
The ideal candidate will have a minimum of 2 years as an Assistant Professor in Pediatric Hematology-Oncology with a focus in hematologic malignancies and a desire to become a leader in clinical trial development. The position includes membership of the USC Norris Comprehensive Cancer Center and an academic appointment through USC Keck School of Medicine at the level of Assistant Professor, Associate Professor, or Professor, appropriate to training and experience.
Program context The Leukemia/Lymphoma Program at CHLA is one of the largest in the nation and sees approximately 120 new patients each year. The program has robust clinical, translational, and basic science research infrastructure, and CHLA is the headquarters for The Therapeutic Advances in Childhood Leukemia/Lymphoma (TACL) Consortium. Other program highlights include comprehensive genomic characterization, bench-to-bedside investigations of novel agents, and leading cellular therapies. The program maintains a close partnership with the CBDI’s Transplantation and Cellular Therapy Program, which performs 80–100 transplants and 20–40 CAR T-cell therapies annually. The CBDI has a cell processing laboratory and cGMP facility, and is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and the National Marrow Donor Program (NMDP).
The CBDI is the largest and top-ranked pediatric hematology-oncology program in the western United States. The U.S. News & World Report ranked CHLA #8 and the CBDI #14 in the nation in 2022-23. The CBDI has a large clinical trials operation supporting programs in hematology, oncology, and transplantation/cellular therapy. CBDI investigators conduct extensive bench-to-bedside research. Research funding in FY22 totaled $54 million with $9 million in new awards. The CBDI hosts an ACGME-accredited pediatric hematology-oncology fellowship training program and 1-year advanced subspecialty fellowships in Transplantation/Cellular Therapy, AYA Oncology, Neuro-Oncology, and Coagulation.
Responsibilities
Assist in leadership of clinical and clinical research activities in pediatric hematologic malignancies.
Partner with the Leukemia/Lymphoma Program Director in program oversight.
Provide patient care and develop and lead clinical trials.
Advance a leading clinical research program and contribute to program growth.
Qualifications
Minimum of 2 years as an Assistant Professor in Pediatric Hematology-Oncology with a focus in hematologic malignancies.
Desire to become a leader in clinical trial development.
Academic appointment through USC Keck School of Medicine at the level of Assistant Professor, Associate Professor, or Professor, appropriate to training and experience.
Program highlights and resources
Strong administrative, clinical, research, and financial support, including staff, infrastructure, endowments, and institutional resources.
CBDI is affiliated with the USC Norris Comprehensive Cancer Center.
CHLA and USC are equal opportunity, affirmative action employers; diversity is valued and encouraged for applicants from underrepresented groups in medicine.
Compensation The annual base salary range for this position is $116,505–$417,709. When extending an offer of employment, USC considers factors such as scope and responsibilities of the position, work experience, education/training, key skills, internal peer equity, applicable laws, contractual stipulations, grant funding, and external market considerations.
Contact for inquiries Alan S. Wayne, M.D.
Director, Cancer and Blood Disease Institute
Head, Division of Hematology-Oncology
Vice Chair, Department of Pediatrics
Alfred E. Mann Family Foundation Chair in Cancer Research
Children’s Hospital Los Angeles
Associate Director, USC Norris Comprehensive Cancer Center
Professor of Pediatrics and Medicine
Keck School of Medicine, University of Southern California
awayne@chla.usc.edu
REQ20134319 | Posted Date: 05/25/2023
#J-18808-Ljbffr